Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMD [NA]

View source ↗

Summary

Clinical trial update on whether trans-resveratrol influences the development of congestive heart failure in early postmenopausal women with hypertension and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trans-resveratrol (trans-resveratrol)

Snippet

Sponsor: OMNIFARMA LLC | Conditions: Heart Failure, Arterial Hypertension | NA | Status: ACTIVE_NOT_RECRUITING